High-risk surgery is a term rarely explicitly defined in scientific articles. There seems to be a common understanding among surgeons and anesthesiologists of what major surgery means. It can be defined as a surgical procedure that is extensive, involves removal of whole or parts of organs, and/or is life-threatening. It has also been defined as a surgical procedure with >1% mortality.1
One possibility for evaluating the perioperative risk is the use of 1 of several risk scores. These include, e.g., the Estimation of Physiological Ability and Surgical Stress,2 the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity,3 and derivatives. These attempt to incorporate patient age and severity of the operative procedure into the risk stratification. The American Society of Anesthesiologists score4 is widely used and easy to apply, but excludes age from its risk analysis. As with all risk scores, they cannot and must not be used to predict the individual risk of a patient.
Progress in the treatment of chronic diseases such as diabetes, hypertension, and coronary artery disease is increasing the prevalence of heart failure.5–8 This is important considering that >75% of all patients with heart failure are >65 years old, and these older patients have the highest incidence of major noncardiac operations.9,10 Furthermore, the prevalence of obesity is rapidly increasing.11 Despite this, improved postoperative outcomes have been documented over the last several decades. Left ventricular dysfunction as a risk factor for hospital mortality after aortic valve surgery for chronic aortic regurgitation was neutralized between 1972 and 2000,12 and the incidence of pneumonia in postoperative patients without epidural analgesia decreased from 34% to 12% between 1971 and 2006.13 A meta-analysis of all English-language literature reporting operative mortality of ruptured abdominal aortic aneurysm (AAA) repair between 1955 and 1998 found a constant mortality reduction of approximately 3.5% per decade.14 In addition, postoperative death rates after surgery for rectal cancer have shown improvement in recent years. A systematic review including all prospective studies of rectal cancer patients receiving radical surgery published between 1990 and 2008 (24,845 patients) identified year of publication as the only statistically significant variable to explain postoperative death rate in a multivariable model.15 Similarly, using longitudinal analyses of cancer registries, improved outcomes for surgically treated gastrointestinal cancers were documented between 1973 and 2000.16 Despite worse clinical and pathological characteristics, survival rates after hepatic resection for colorectal metastases increased between 1985 and 2004.17 Likely contributing factors to a better outcome are improvements in patient selection and perioperative management. This review provides a basis for the evaluation of factors with the potential to further improve outcome in high-risk surgery.
Patients: Comorbidities and Risk Factors
Impact of Age
Age was previously identified as one of the most important, if not the single most predictive, risk factors for morbidity and mortality after high-risk interventions, including but not limited to cardiac surgery,18 major pancreatic surgery,19 and gastric cancer surgery.20 In a recent retrospective cohort study, 121 hospitals participated in the American College of Surgeons National Surgical Quality Improvement Program.21 A total of 24,747 patients requiring upper and lower abdominal surgery were evaluated. Overall perioperative morbidity was 1.2 to 2 times higher and mortality 2.9 to 6.7 times higher in elderly patients (defined as >75 years) than in younger patients after adjusting for differences in preoperative comorbidities. Irrespective of procedure type, the elderly were significantly more likely to experience cardiac, pulmonary, and renal complications, whereas surgical site infections, postoperative bleeding events, deep venous thromboses, and rates of return to the operating room did not differ.
Although a patient's age cannot be changed, an in-depth understanding of the altered physiology associated with increased age may help to provide better care and lead to adapted treatment strategies. Young patients can readily increase their cardiac output, by an increase in stroke volume and/or heart rate, but the older heart has an altered muscle wall that limits the heart's mechanical and contractile abilities.22 In addition, diastolic dysfunction is common in the older patient.23 Accordingly, the stroke volume is limited under stress, and thus the elderly patient has a decreased cardiac reserve. Increased chest wall rigidity, weakening of the respiratory muscles due to loss of muscle mass, and reduced surface area for alveolar gas exchange give rise to a reduced ability to adapt to hypoxia. Any respiratory challenge can thus put older patients at risk for perioperative and postoperative hypoxemia.24 Moreover, sleep apnea syndrome may aggravate hypoxia.25 Elderly patients also seem to have a particularly high risk of arterial and venous thromboembolism.26 Altered pharmacokinetics and pharmacodynamics put these patients at risk for inadequate drug dosing and adverse drug effects.27 As an example, a decreasing proportion of cardiac output directed to vessel-rich tissues,28 and increasing tissue and blood solubility of inhaled anesthetics with age29 may result in progressively slower onset and offset of their effects. Indeed, it has been shown that age significantly reduces the requirements of sevoflurane.30
Finally, protein energy malnutrition and involuntary weight loss are common problems in the elderly patient population. As an example, a retrospective review of 123 patients older than 65 years with major burns reported malnutrition to be present in 61%.31 There was a significant increase in infection rate, a decrease in the rate of healing of a standard skin graft donor site, and an increase in length of stay in the malnourished group compared with an adequately nourished elderly burn population. Mortality in malnourished patients was 17%, compared with 9% in the well-nourished patients. Elderly patients are also at high risk of abnormal hematocrit values.32 In a retrospective study including 310,311 patients aged >65 years undergoing major noncardiac surgery between 1997 and 2004, 30-day mortality and cardiac event rates increased monotonically, with either positive or negative deviations from normal hematocrit levels.32 Postoperative cognitive dysfunction occurs in a significant proportion of patients in the early weeks after major noncardiac surgery, with the elderly being more at risk.33 In 110 prospectively studied patients aged >65 years undergoing major surgery, preoperative markers related to 6-month mortality included impaired cognition, recent falls, low albumin, anemia, functional dependence, and increased comorbidities.34 Logistic regression identified any functional dependence as the strongest predictor of 6-month mortality (odds ratio 14).
From the available evidence, it can be concluded that attempts to improve preoperative nutritional status, preoperative assessment using geriatric-specific markers, better perioperative organ function monitoring and support, and postoperative measures to reduce delirium and increase patient autonomy may all have potential or at least provide options for improving outcome for the elderly patient group.
Impact of Smoking
Patients who smoke have an increased risk of intra- and postoperative complications, particularly of a pulmonary or cardiovascular nature, compared with nonsmoking patients.35,36 As carbon monoxide (CO) preferentially binds to hemoglobin in place of oxygen, the short-term effects of cigarette smoking include elevated blood CO levels that result in a 3% to 12% reduction of oxygen availability in the periphery.37 Moreover, nicotine stimulates a surgical stress response that resembles a “cardiac workout,” with increases in heart rate, arterial blood pressure, and peripheral vascular resistance. These effects may not negatively influence an otherwise fit patient, but the imbalance between oxygen availability and oxygen consumption in a smoker may produce a detrimental effect. In the setting of a surgical intervention, particularly in high-risk surgery, the surgery and anesthesia place a certain unavoidable strain on the patient's cardiovascular functions; thus, additional stress related to smoking may tip the balance and result in hypoxemia in the vital organs.
The short-term benefits of smoking cessation before surgery (decreases in CO and nicotine levels) are observed as early as 24 to 48 hours after the last cigarette.37 However, a substantially longer smoking abstinence of several weeks before surgery is required for a reduction in pulmonary complications.38 In a randomized controlled trial including 117 patients undergoing different types of surgery such as cholecystectomy and hip or knee prosthesis, smoking cessation therapy with individual counseling and nicotine substitution was started 4 weeks before surgery and continued 4 weeks postoperatively.39 The control group received standard care. The overall complication rate in the control group was significantly higher (41% vs 21%). Relative risk reduction for the primary outcome of any postoperative complication was 49% and number needed to treat was 5. An analysis per protocol showed that abstainers had fewer complications (15%) than those who continued to smoke or only reduced smoking (35%).
In a recent meta-analysis including 11 randomized controlled trials with 1194 patients, smoking interventions significantly reduced the occurrence of complications (pooled risk ratio 0.6; 95% confidence interval 0.4–0.8).40 Intensive interventions increased smoking cessation rates both before operation and up to 12 months thereafter. The effects of medium to less intensive interventions were not significant.
The available data suggest, therefore, that surgical patients may benefit from intensive preoperative smoking cessation interventions. These include individual counseling, initiated at least 4 weeks before the scheduled operation, and nicotine replacement therapy.
Impact of Obesity
The literature is full of reports pointing out the disadvantages of obesity in the preoperative setting; increases in morbidity and mortality are only 2 of the many aspects evaluated.41 The association between obesity and the inflammatory response and the pathogenesis of obesity-related comorbidities, such as Type 2 diabetes, have been well documented.42 Obese patients have high levels of C-reactive protein (CRP) and tumor necrosis factor (TNF)-α43 in addition to an increased white cell count.44 More recently, several studies have focused on the effect of obesity on the innate immune system, showing that overweight people have elevated neutrophil activation compared with normal-weight subjects.45 Elevated CRP and white blood cell counts (especially high neutrophil counts) have been identified as significant risk factors for stroke46 and cardiac events, including cardiac death.47 Thus, elevated inflammatory markers in obese patients act as surrogate markers for postoperative complications.
Recently, Tokunaga et al.48 evaluated the effects of general obesity on postoperative complications in extensive abdominal surgery (open gastrectomy). In particular, they identified visceral fat as a risk factor for postoperative intraabdominal infection, prolonged hospital stay, and death.
In a prospective, multicenter, observational study of 30-day outcomes in consecutive patients undergoing bariatric surgical procedures at 10 clinical sites in the United States from 2005 through 2007, 4.3% of patients had at least 1 major adverse outcome.49 A history of deep vein thrombosis or pulmonary embolus, a diagnosis of obstructive sleep apnea, impaired functional status, and extreme values of body mass index (BMI) were each associated with an increased risk of the composite end point.
The authors of a review found good evidence that obesity is a risk factor for wound infection after colorectal surgery.50 Obesity may increase the risk of wound dehiscence, incisional site herniation, and stoma complications. Obesity is linked to anastomotic leak, and obese patients undergoing rectal resections may be at particular risk.50 Furthermore, operation times are longer for rectal procedures in obese patients, and obese patients undergoing laparoscopic colorectal surgery are at increased risk of conversion to an open procedure. However, hospital stay does not seem to be prolonged.
Although it is evident that obesity increases perioperative complications, the effect of weight reduction before scheduled surgery remains to be determined.
Perioperative Nutritional Support: Pro or Con?
Previously published data clearly show that malnourished patients who require major operations are predisposed to infectious complications and poor outcome.51,52 Adequate perioperative nutritional support resulted in a reduction of postoperative complications.53 A low preoperative BMI (kg/m2) may be regarded as an overall indicator of the size of the patient's reserves; a BMI <20 kg/m2 is an accepted indicator of malnutrition. However, it has been recognized that acutely malnourished patients may still have a normal or even elevated BMI. In an increasingly obese population, BMI alone is insufficient to assess an individual's nutritional status. More useful assessments of malnutrition consider the rate of weight loss or the percentage loss of usual body weight; an example is the Nutritional Risk Screening developed by Kondrup et al.54
Nutritional status was assessed between 1999 and 2002 in a cohort of 460 patients undergoing major elective surgery using the Nutritional Risk Index, Maastricht Index, Subjective Global Assessment, and Mini Nutritional Assessment.55 Twenty patients died during the study period and 42 patients had 2 or more complications. The frequency of malnutrition was 58%, 64%, and 67% as assessed by the Subjective Global Assessment, Nutritional Risk Index, and Maastricht Index, respectively. Morbidity rates, especially severe infectious and noninfectious complications, were significantly higher in malnourished patients in all nutritional indices.
Serum protein markers such as albumin (for evaluating long-term nutritional status) and prealbumin (for evaluating acute responses to nutritional support) have been shown to be useful additional measurements for assessing nutritional status. Low albumin levels have been identified as an independent risk factor for postoperative morbidity and mortality.52,56 For starving, malnourished patients, nutritional support leads to an improved postoperative course that outweighs any theoretical risks of potentially increased tumor growth. However, it should be emphasized that, although preoperative enteral or parenteral nutritional support clearly benefits surgical cancer patients,57 a systematic review showed that “preventive” administration of parenteral support in nonmalnourished patients did not positively influence outcome and may even be potentially harmful for certain patient subgroups.58
More recently, the concept of immunonutrition has evolved, in which enteral formulas are supplemented with arginine and glutamine, nucleotides, or omega-3 fatty acids in an attempt to positively modulate the immune system. The notion that immunomodulation can improve the immune response was supported in certain studies that showed reduced overall and, in particular, infectious complications.59 In a double-blind study, esophageal cancer surgery patients were randomized to a standard enteral nutrition formula or a formula enriched with 2.2 g eicosapentaenoic acid (EPA)/d for 5 days preoperatively (orally) and 21 days postoperatively (jejunostomy).60 The EPA group maintained all aspects of body composition postoperatively, whereas patients in the standard enteral nutrition group lost significant amounts of fat-free mass compared with the EPA group. The EPA group had a significantly attenuated stress response to TNF-α, interleukin (IL)-10, and IL-8. However, this did not translate into a reduced incidence of major complications.
In another study, 196 well-nourished patients undergoing resection for pancreatic or gastric cancer between 2004 and September 2007 were randomized to receive postoperative enteral nutrition with immunostimulating diet or standard oligopeptic diet.61 Complications were observed in 23% and 25%, respectively (not significant). There were no differences in liver and kidney function, visceral protein turnover, or treatment tolerance between the groups.
The benefits of immunonutrition, therefore, remain debatable. A major drawback is the significantly higher costs involved with the administration of immunonutrition.
Whereas perioperative nutrition in the malnourished patient can improve postoperative outcome, immunonutrition seems to attenuate the inflammatory response and interferes with certain immune functions in selected patient groups.
Consequences of Major Surgery
Effects of Surgery on Inflammation and Immune Response
Major abdominal surgery causes a hyperdynamic and hypermetabolic host response that seems to be more pronounced in older patients.62 Tissue injury during major surgery is aggravated by repeated ischemia-reperfusion events, particularly during vascular surgery. Both tissue injury and ischemia-reperfusion may lead to systemic effects. Even in the 1970s, we understood that major surgical interventions resulted in immune cell alterations, with reductions in total T lymphocytes, cytotoxic T cells, and natural killer cells.63 The surgery-induced postoperative inflammatory response combined with paralysis of the cell-mediated immune system has since been confirmed in numerous other studies.64,65 It has been shown that genes encoding IL-6 and components of the local renin-angiotensin system are activated early during aortic surgery.66 The resulting systemic inflammatory reaction is followed by impaired pulmonary function.66 In contrast, systemic inflammation seems to be less severe or even absent during abdominal surgery without tissue ischemia. Major surgery also causes the depression of macrophage antigen presentation capacity, a factor that contributes significantly to cell-mediated immunity.67
When visceral ischemia is prolonged during major surgery, the levels of TNF-α, IL-6, IL-8, and IL-10 become elevated.68 The magnitude of this inflammatory reaction seems to correlate with the frequency and magnitude of postoperative organ dysfunction.68,69 Postoperative organ failures and infection are complications associated with a bad outcome, particularly after major surgery for cancer. It has been shown that prolonged operation times, the presence of remote infection at the time of the operation, and long preoperative hospital stays are important risk factors for infectious complications after surgery.70 In a large database including 4700 patients who underwent noncolorectal abdominal surgery, independent risk factors for postoperative infection included age, a very low or high BMI, liver cirrhosis, vertical abdominal incision, and suturing or anastomosis of the bowel.71
To combat postoperative immunodepression, perioperative IL-2 administration was tested in a phase II randomized trial to analyze its effect on patients with radically operable gastric cancer.72 Compared with patients who received no IL, patients who received IL-2 had a significant increase in total and CD4-positive lymphocytes and did not experience any anesthesia-related or surgical complications.73
There are some recent studies evaluating perioperative antiinflammatory therapies in patients. In a prospective, randomized, double-blind, placebo-controlled trial involving 36 high-risk patients undergoing cardiac surgery, the effects of stress doses of hydrocortisone on markers of systemic inflammation were investigated.73 Patients treated with hydrocortisone had significantly lower levels of IL-6 and higher levels of IL-10, resulting in an attenuated change in IL-6/IL-10 ratio 4 hours after cardiopulmonary bypass. Patients in the hydrocortisone group also had a shorter duration of catecholamine support, a shorter length of stay in the intensive care unit (ICU), and a lower incidence of postoperative atrial fibrillation. Oxidative stress is involved in the development of secondary tissue damage and organ dysfunction, and “micronutrients” could theoretically contribute to the antioxidant defense. In a prospective, double-blind trial, 200 patients admitted to an ICU with organ failure after complicated cardiac surgery, major trauma, or subarachnoid hemorrhage were randomized to receive IV supplements of selenium, zinc, vitamin C, and vitamin B1 for 5 days versus placebo.74 The incidence of postoperative acute kidney failure and subsequent decrease in sequential organ failure assessment score were similar between the groups. Although CRP decreased more quickly in the intervention group, neither infectious complications nor length of hospital stay differed between groups.
Cardioprotection with β receptor antagonists can improve the outcome in high-risk patients undergoing elective surgery. In a randomized, controlled trial, 42 ICU patients aged >55 years were randomized to receive continuous β-blockers or standard care.75 Levels of IL-6, but not IL-1β, decreased over time in patients receiving a β-blocker, whereas levels in controls remained unchanged. There were no complications related to the use of β-blockers.
Perioperative hypothermia may contribute to intraoperative and postoperative complications. A recent systematic review of the literature found 25 studies encompassing 3599 patients in various surgical disciplines.76 Of these, 19 were randomized trials involving 1785 patients. Not warming the patient during surgery was associated with significant hypothermia. Normothermic patients had significantly less pain, a lower incidence of wound infection, and reduced blood loss, most likely because of the prevention of hypothermia-induced coagulopathy.
Further studies are needed to evaluate the effect of immunomodulating and antiinflammatory compounds on postoperative outcome in high-risk surgery patients. “Low-dose” antiinflammatory drugs may have the potential to reduce inflammation and lead to faster organ recovery in selected patient groups.73
Effects of Hemorrhage
Several studies have shown that, after hemorrhagic shock, lymphocyte function is severely depressed for up to 5 days postoperatively.77,78 In addition to the effects on T cell populations, the splenic B cell capacity for antibody production is also significantly reduced.79 Significant blood loss during surgery is associated with a cascade of inflammatory responses, with circulating TNF-α levels increasing as early as 30 minutes after the initial injury.80 Together with TNF-α, increases in other proinflammatory cytokines, including IL-6 and IL-1,81 may contribute to initiating the development of multiple organ dysfunction after severe hemorrhagic shock.
In trauma patients, the release of proinflammatory cytokines seems to be related to the magnitude of surgery, rather than to the duration of the procedure.82 However, the cytokine release is also associated with the degree of blood loss.
The Surgical Approach
In an attempt to maximally reduce surgical trauma, standard laparotomy has now been routinely replaced by far less invasive laparoscopic techniques. The latter include a wide variety of surgical interventions, including the “gold standard” laparoscopic cholecystectomy,83 laparoscopic colorectal resections, and gastric bypass operations for morbid obesity or antireflux surgery, to name but a few minimally invasive interventions. Laparoscopic surgery reduces postoperative pain, accelerates postoperative recovery, and shortens hospital stay84; in addition, it provides potential solutions for particularly fragile, high-risk patients by reducing overall surgical trauma.
In a prospective, multicenter, double-blind trial, patients were randomized to either laparoscopic or open sigmoid resection between 2002 and 2006. Although laparoscopic resection took longer, it was associated with a 15% reduction in major complication rates, less pain, improved quality of life, and shorter hospitalization time.85
Interestingly, sometimes patients with high-risk and major comorbidities are denied laparoscopic interventions. Contraindications for these patients include the necessary abdominal insufflation, the patient positioning (sometimes prolonged periods in Trendelenburg or anti-Trendelenburg positioning), and potentially longer operating times. Yet, an observational cohort study found some evidence that these patients are likely to benefit from minimal trauma and reduced blood loss.86
Reduced intraoperative bleeding has been documented with laparoscopic hepatic resection,87 and a Cochrane analysis examining short-term postoperative outcome after laparoscopic colorectal surgery also showed reduced blood loss, reduced local (wound) complications, and improved postoperative lung function compared with open surgery.84
In the last 2 decades, endovascular repair as an alternative to open vascular surgery has become popular. In a multicenter clinical trial of 881 veterans, postoperative outcome of endovascular and open repair of AAA was compared between 2002 and 2008.88 Whereas perioperative mortality was lower for endovascular repair, 2-year mortality was similar in both groups. Patients in the endovascular repair group had reduced median procedure time, blood loss, transfusion requirements, duration of mechanical ventilation, hospital stay (3 vs 7 days), and ICU stay (1 vs 4 days). There were no differences between the 2 groups in major morbidity, procedure failure, secondary therapeutic procedures, aneurysm-related hospitalizations, health-related quality of life, or erectile function.
Endovascular aneurysm repair was also compared with open repair of inferior AAAs in a single-center retrospective study including 677 patients between 1996 and 2005.89 Endovascular repair was associated with reduced blood loss, reduced length of ICU and hospital stay, and increased number of patients discharged home compared with open repair.
Accordingly, less-invasive procedures seem to have clinically significant advantages and can be recommended, especially for high-risk patients.
The Effect of Anesthetic Management
All anesthetic drugs may alter the hemodynamic status by blunting the sympathetic output of the central nervous system or by directly causing peripheral vasodilation. Anesthetics may also affect cellular functions of other organs. Whereas there is evidence that neither total IV nor inhaled anesthesia has significant effects on mesenteric perfusion in the absence of surgical stimulation,90 hepatocellular disintegrity and subclinical liver dysfunction have been demonstrated with both forms of anesthesia91,92 during open surgery and laparoscopic surgical interventions.93
The time-dependent expression of alveolar macrophage genes for proinflammatory cytokines was evaluated in patients during propofol and isoflurane anesthesia.94 Gene expression for IL-1β, IL-6, IL-8, interferon γ (IFN-γ), and TNF-α increased 10-fold during surgery and anesthesia. The increases in IL-8 and IFN-γ were up to 3 times larger during isoflurane than propofol anesthesia.
To separate the effects of mechanical ventilation and general anesthesia, rats were allocated to spontaneous or mechanical ventilation with and without exposure to halothane, enflurane, isoflurane, or sevoflurane.95 TNF-α gene expression from pulmonary lavage cells was greater during mechanical than spontaneous ventilation and in nonventilated controls. During exposure to volatile anesthetics, gene expression for IL-1β, IFN-γ, and TNF-α all increased significantly compared with mechanical ventilation alone.
Alveolar macrophages' phagocytosis and microbicidal activity was also measured in patients anesthetized with isoflurane or propofol for orthopedic surgery.96 The fraction of alveolar macrophages ingesting particles, the number of particles ingested, and microbicidal function decreased significantly over time, with a greater decrease during isoflurane compared with propofol anesthesia. These data suggest that pulmonary defenses are modulated by the type (and duration) of anesthesia. Other effects of anesthetics include oxidant and antioxidant properties.97
Anesthetics may have further effects with the potential to interfere with postoperative outcome. One example is the inhibition of the response to adrenocorticotrophic hormone stimulation. This is best known for etomidate,98 but may also occur after propofol and thiopental anesthesia,99 albeit less consistently.
Thoracic, but not lumbar, epidural anesthesia appears to increase liver blood flow after major abdominal surgery.100,101 However, there are also studies demonstrating a selective decrease in hepatic blood flow.102 This fact precludes recommendation of epidural anesthesia for potential improvement of liver perfusion. Nevertheless, thoracic epidural anesthesia may blunt the reduction in subcutaneous tissue oxygen tension caused by surgical stress and adrenergic vasoconstriction during surgery,103 and may prevent stress-induced perioperative impairment of proinflammatory lymphocyte function.104 The potential of epidural anesthesia/analgesia to improve postoperative outcome and attenuate the physiological response to surgery has been documented. Reviews including retrospective, prospective, and meta-analysis studies found improvement in surgical outcomes through beneficial effects on perioperative pulmonary function, surgical stress response, and analgesia.105,106 Nevertheless, in unselected patients undergoing gastrointestinal surgery, epidural analgesia does not seem to reduce anastomotic leakage, intraoperative blood loss, transfusion requirement, risk of thromboembolism, cardiac morbidity, or hospital stay compared with conventional analgesia.106 Complications of epidural anesthesia/analgesia range from transient paresthesias to potentially devastating epidural hematomas in rare cases.
Accordingly, the beneficial effects of epidural analgesia seem largely to be related to improved lung functions and better maintained analgesia with an acceptable risk/benefit ratio.
Although the importance of perioperative fluid restriction has been emphasized, fluid restriction regimens may increase the likelihood of perioperative hypovolemia and splanchnic ischemia. In a group of patients who underwent major (mainly cardiovascular) surgery, it was shown that low gastric pH measured during the intraoperative period was associated with increased postoperative complications and costs.107 Gastrointestinal perfusion is often compromised earlier than perfusion in other vascular beds under conditions of imbalanced tissue oxygen delivery and needs, e.g., hypovolemia, stress, and increased metabolic demand.108 There is a strong association between relative gastric luminal hypercarbia (suggesting relative gastrointestinal hypoperfusion) and postoperative organ dysfunction, including the gastrointestinal tract.109–111 Therefore, restoration of oxygen delivery, especially to the splanchnic bed, is of critical importance. However, the characteristics of optimal perioperative fluid management remain controversial.
Until recently, the general approach to perioperative intravascular volume management was the administration of large amounts of fluids and sodium, with the goal of maintaining organ perfusion, preserving function, and thus improving patient outcome. During the last few years, an alternative approach has been suggested and explored (reviewed in an article by Walsh et al.112 in 2008). A series of trials demonstrated that postoperative patients could be managed successfully with quantities of fluid that previously would have been considered inadequate.113–115 In these trials, fluid-restricted groups had fewer complications, less edema, and earlier return of bowel function. Renal impairment was a rare event in the fluid-restricted group. In contrast, in another study, there were no differences in complication rates or the return of bowel function in patients with restricted versus liberal volume management.116 It has been suggested that the lack of effect in that trial may have been attributable to the restriction of intraoperative fluid administration in both arms of the trial.114 Another study showed that when transesophageal echocardiography was used to maintain preoperative left ventricular end-diastolic volume and cardiac output during colorectal surgery, the patients required lower than commonly recommended crystalloid solution delivery rates, especially during laparoscopic surgery.117
In patients undergoing elective major abdominal surgery, a restricted (1.5 L/24 hours) versus standard (2.5 L/24 hours) postoperative IV fluid regime increased postoperative hospital stay by 4 days and increased major complications.118 No differences were found in time to restore gastric functions between the groups. In contrast, in patients after elective abdominal vascular surgery, a restricted fluid regime resulted in shorter postoperative hospital stay (8 days vs 12 days).119 In patients undergoing elective major abdominal surgery, intraoperative fluid management using systolic pressure variation versus routine care increased the amount of administered fluid but did not alter organ perfusion and function.120 In another prospective randomized study in patients undergoing open AAA repair, standard fluid management resulted in a cumulative fluid balance of 8.2 L on postoperative day 5 vs 2.6 L for restricted management.121 Total and postoperative length of stay in hospital was reduced by 50% in the restricted group. In a randomized study in patients aged >50 years undergoing emergency abdominal surgery, use of pulse pressure variation measurements to guide fluid boluses was not associated with a change in postoperative renal function.122
In a recent review of prospective, randomized studies comparing the effect of 2 different fixed fluid volumes on postoperative clinical outcome in major surgery (n = 7), it was determined that a liberal intraoperative fluid regimen ranged from 2.8 to 5.4 L and a restrictive regimen from 1 to 2.7 L.123 The period for fluid therapy and outcome end points were inconsistently defined and only 2 studies reported perioperative care principles and discharge criteria. Whereas 3 studies found an improved outcome in terms of morbidity and/or hospital stay with a restrictive fluid regimen, 2 studies found no difference and 2 studies found differences in other selected outcome variables. We conclude with the authors that differences in definitions and methodology and conflicting results preclude evidence-based guidelines for procedure-specific perioperative fixed-volume regimens so far.123
Cancer, organ dysfunction, and individual specific risk factors contribute to increased risk after major surgery. Adequate nutritional support, reduction of invasiveness, shorter operation times, regional or combined regional/general anesthesia, and target-controlled fluid management are options for reducing postoperative morbidity.
Despite all efforts to improve outcome and the many available risk stratification scores, an individual's actual risk cannot be precisely predicted. Further studies are needed to evaluate the value of “bundles” of interventions and whether they can improve outcome after major surgery.
1. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361:1368–75
2. Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today 1999;29:219–25
3. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991;78:355–60
4. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941:281–4
5. Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg 2003;238:170–7
6. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397–402
7. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133:703–12
8. Hernandez AF, Whellan DJ, Stroud S, Sun JL, O'Connor CM, Jollis JG. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 2004;44:1446–53
10. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997;45:968–74
11. World Health Organization. Obesity: preventing and managing the global epidemic. WHO Obesity Technical Report Series 894. Geneva, Switzerland: World Health Organization, 2000
12. Blackstone EH. Thinking beyond the risk factors. Eur J Cardiothorac Surg 2006;29:645–52
13. Pöpping DM, Elia N, Marret E, Remy C, Tramèr MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg 2008;143:990–9
14. Bown MJ, Sutton AJ, Bell PR, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 2002;89:714–30
15. Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg 2010;251:807–18
16. O'connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY. A report card on outcomes: are we improving? J Surg Res 2004;121:214–21
17. House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR, D'Angelica MI. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010;210:744–52
18. Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Vento AE, Salminen US. Risk evaluation of cardiac surgery in octogenarians. J Cardiothorac Vasc Anesth 2006;20:526–30
19. Riall TS, Reddy DM, Nealon WH, Goodwin JS. The effect of age on short-term outcomes after pancreatic resection: a population-based study. Ann Surg 2008;248:459–67
20. Gretschel S, Estevez-Schwarz L, Hunerbein M, Schneider U, Schlag PM. Gastric cancer surgery in elderly patients. World J Surg 2006;30:1468–74
21. Bentrem DJ, Cohen ME, Hynes DM, Ko CY, Bilimoria KY. Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch Surg 2009;144:1013–20
22. Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth 2000;85:763–78
23. Sanders D, Dudley M, Groban L. Diastolic dysfunction, cardiovascular aging, and the anesthesiologist. Anesthesiol Clin 2009;27:497–517
25. Bettelli G. High risk patients in day surgery. Minerva Anestesiol 2009;75:259–68
26. Chaggar PS, Channer KS. Current issues in thromboprophylaxis in the elderly. Drugs Aging 2008;25:1049–60
27. Delafuente JC. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient. Consult Pharm 2008;23:324–34
28. Eger EI. Uptake and distribution. In: Miller RD, ed. Miller's Anesthesia. 6th ed. Philadelphia: Elsevier, 2005:131–54
29. Lerman J, Schmitt-Bantel BI, Gregory GA, Willis MM, Eger EI II. Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 1986;65:307–11
30. Cortínez LI, Trocóniz IF, Fuentes R, Gambús P, Hsu YW, Altermatt F, Muñoz HR. The influence of age on the dynamic relationship between end-tidal sevoflurane concentrations and bispectral index. Anesth Analg 2008;107:1566–72
31. Demling RH. The incidence and impact of pre-existing protein energy malnutrition on outcome in the elderly burn patient population. J Burn Care Rehabil 2005;26:94–100
32. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297:2481–8
33. Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology 2007;106:572–90
34. Robinson TN, Eiseman B, Wallace JI, Church SD, McFann KK, Pfister SM, Sharp TJ, Moss M. Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg 2009;250:449–55
35. Myles PS, Iacono GA, Hunt JO, Fletcher H, Morris J, McIlroy D, Fritschi L. Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus nonsmokers. Anesthesiology 2002;97:842–7
36. Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest 1998;113:883–9
37. Pearce AC, Jones RM. Smoking and anesthesia: preoperative abstinence and perioperative morbidity. Anesthesiology 1984;61:576–84
38. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989;64:609–16
39. Lindström D, Sadr Azodi O, Wladis A, Tønnesen H, Linder S, Nåsell H, Ponzer S, Adami J. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008;248:739–45
40. Thomsen T, Tønnesen H, Møller AM. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg 2009;96:451–61
41. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 2009;208:53–61
42. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004;14:589–600
43. Ramalho R, Guimaraes C, Gil C, Neves C, Guimaraes JT, Delgado L. Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. Obes Surg 2009;19:915–20
44. Chen SB, Lee YC, Ser KH, Chen JC, Chen SC, Hsieh HF, Lee WJ. Serum C-reactive protein and white blood cell count in morbidly obese surgical patients. Obes Surg 2009;19:461–6
45. Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009;17:2014–8
46. Rordorf G, Koroshetz W, Efird JT, Cramer SC. Predictors of mortality in stroke patients admitted to an intensive care unit. Crit Care Med 2000;28:1301–5
47. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638–43
48. Tokunaga M, Hiki N, Fukunaga T, Ogura T, Miyata S, Yamaguchi T. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg 2009;96:496–500
49. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445–54
50. Gendall KA, Raniga S, Kennedy R, Frizelle FA. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007;50:2223–37
51. Windsor A, Braga M, Martindale R, Buenos R, Tepaske R, Kraehenbuehl L, Weimann A. Fit for surgery: an expert panel review on optimising patients prior to surgery, with a particular focus on nutrition. Surgeon 2004;2:315–9
52. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36–42
53. Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio L, Bonfanti G, Piacenza S. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr 2000;24:7–14
54. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003;22:321–36
55. Kuzu MA, Terzioğlu H, Genç V, Erkek AB, Ozban M, Sonyürek P, Elhan AH, Torun N. Preoperative nutritional risk assessment in predicting postoperative outcome in patients undergoing major surgery. World J Surg 2006;30:378–90
56. Poulsen M, Trezza M, Atimash GH, Sorensen LT, Kallehave F, Hemmingsen U, Jorgensen LN. Risk factors for morbidity and mortality following gastroenterostomy. J Gastrointest Surg 2009;13:1238–44
57. Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 2007;26:698–709
58. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001;121:970–1001
59. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002;132:805–14
60. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, McHugh A, McCormack D, Flood P. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009;249:355–63
61. Klek S, Kulig J, Sierzega M, Szczepanek K, Szybiński P, Scislo L, Walewska E, Kubisz A, Szczepanik AM. Standard and immunomodulating enteral nutrition in patients after extended gastrointestinal surgery: a prospective, randomized, controlled clinical trial. Clin Nutr 2008;27:504–12
62. Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Kawasaki Y, Miki H, Kagawa H, Ioki H, Nakamura Y. Postoperative host responses in elderly patients after gastrointestinal surgery. Hepatogastroenterology 2006;53:730–5
63. Slade MS, Simmons RL, Yunis E, Greenberg LJ. Immunodepression after major surgery in normal patients. Surgery 1975;78:363–72
64. Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W. Monocyte function before and after surgical trauma. Dig Surg 1998;15:102–4
65. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983;23:775–87
66. Adembri C, Kastamoniti E, Bertolozzi I, Vanni S, Dorigo W, Coppo M, Pratesi C, De Gaudio AR, Gensini GF, Modesti PA. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 2004;32:1170–7
67. Welborn MB, Oldenburg HS, Hess PJ, Huber TS, Martin TD, Rauwerda JA, Wesdorp RI, Espat NJ, Copeland EM III, Moldawer LL, Seeger JM. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 2000;28:3191–7
68. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993;80:205–9
69. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002;17:451–8
70. Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM. Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996; 24:1–6
71. Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg 2003;138:314–24
72. Romano F, Piacentini MG, Franciosi C, Caprotti R, De Fina S, Cesana G, Uggeri F, Conti M. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients. Hepatogastroenterology 2004;51:1872–6
73. Weis F, Beiras-Fernandez A, Schelling G, Briegel J, Lang P, Hauer D, Kreth S, Kaufmann I, Lamm P, Kilger E. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med 2009;37:1685–90
74. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, Chioléro RL. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 2008;12:R101
75. Friese RS, Barber R, McBride D, Bender J, Gentilello LM. Could beta blockade improve outcome after injury by modulating inflammatory profiles? J Trauma 2008;64:1061–8
76. Sajid MS, Shakir AJ, Khatri K, Baig MK. The role of perioperative warming in surgery: a systematic review. Sao Paulo Med J 2009;127:231–7
77. Zellweger R, Ayala A, DeMaso CM, Chaudry IH. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995;4:149–53
78. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987;122:62–8
79. Abraham E, Freitas AA. Hemorrhage in mice induces alterations in immunoglobulin-secreting B cells. Crit Care Med 1989;17:1015–9
80. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 1990;2:170–4
81. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813–9
82. Pape HC, Griensven MV, Hildebrand FF, Tzioupis CT, Sommer KL, Krettek CC, Giannoudis PV; Epoff Study Group. Systemic inflammatory response after extremity or truncal fracture operations. J Trauma 2008;65:1379–84
83. Keus F, de Jong JA, Gooszen HG, van Laarhoven CJ. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006;4:CD006231
84. Schwenk W, Haase O, Neudecker J, Muller JM. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev 2005;3:CD003145
85. Klarenbeek BR, Veenhof AA, Bergamaschi R, van der Peet DL, van den Broek WT, de Lange ES, Bemelman WA, Heres P, Lacy AM, Engel AF, Cuesta MA. Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial—short-term results of the Sigma Trial. Ann Surg 2009;249:39–44
86. Marks JH, Kawun UB, Hamdan W, Marks G. Redefining contraindications to laparoscopic colorectal resection for high-risk patients. Surg Endosc 2008;22:1899–904
87. Dagher I, Di Giuro G, Dubrez J, Lainas P, Smadja C, Franco D. Laparoscopic versus open right hepatectomy: a comparative study. Am J Surg 2009;198:173–7
88. Matsumura JS, Kohler TR, Lin PH, Jean-Claude JM, Cikrit DF, Swanson KM, Peduzzi PN; Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009;302:1535–42
89. Chahwan S, Comerota AJ, Pigott JP, Scheuermann BW, Burrow J, Wojnarowski D. Elective treatment of abdominal aortic aneurysm with endovascular or open repair: the first decade. J Vasc Surg 2007;45:258–62
90. Zwijsen JH, Bovill JG, Geelkerken RH, Delahunt TA, van Bockel JH, Hermans J. Comparison of sufentanil/propofol versus isoflurane/nitrous oxide anaesthesia on mesenteric artery blood flow. Anaesthesia 1996;51:1060–3
91. Tiainen P, Rosenberg PH. Hepatocellular integrity during and after isoflurane and halothane anaesthesia in surgical patients. Br J Anaesth 1996;77:744–7
92. Tiainen P, Lindgren L, Rosenberg PH. Disturbance of hepatocellular integrity associated with propofol anaesthesia in surgical patients. Acta Anaesthesiol Scand 1995;39:840–4
93. Kotake Y, Takeda J, Matsumoto M, Tagawa M, Kikuchi H. Subclinical hepatic dysfunction in laparoscopic cholecystectomy and laparoscopic colectomy. Br J Anaesth 2001;87:774–7
94. Kotani N, Hashimoto H, Sessler DI, Yasuda T, Ebina T, Muraoka M, Matsuki A. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 1999;89:1250–6
95. Kotani N, Takahashi S, Sessler DI, Hashiba E, Kubota T, Hashimoto H, Matsuki A. Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. Anesthesiology 1999;91:187–97
96. Kotani N, Hashimoto H, Sessler DI, Kikuchi A, Suzuki A, Takahashi S, Muraoka M, Matsuki A. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 1998;89:1125–32
97. Allaouchiche B, Debon R, Goudable J, Chassard D, Duflo F. Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth Analg 2001;93:981–5
98. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984;310:1415–21
99. Kenyon CJ, McNeil LM, Fraser R. Comparison of the effects of etomidate, thiopentone and propofol on cortisol synthesis. Br J Anaesth 1985;57:509–11
100. Kortgen A, Silomon M, Pape-Becker C, Buchinger H, Grundmann U, Bauer M. Thoracic but not lumbar epidural anaesthesia increases liver blood flow after major abdominal surgery. Eur J Anaesthesiol 2009;26:111–6
101. Vaisanen O, Parviainen I, Ruokonen E, Hippelainen M, Berg E, Hendolin H, Takala J. Epidural analgesia with bupivacaine does not improve splanchnic tissue perfusion after aortic reconstruction surgery. Br J Anaesth 1998;81:893–8
102. Meierhenrich R, Wagner F, Schütz W, Rockemann M, Steffen P, Senftleben U, Gauss A. The effects of thoracic epidural anesthesia on hepatic blood flow in patients under general anesthesia. Anesth Analg 2009;108:1331–7
103. Kabon B, Fleischmann E, Treschan T, Taguchi A, Kapral S, Kurz A. Thoracic epidural anesthesia increases tissue oxygenation during major abdominal surgery. Anesth Analg 2003; 97:1812–7
104. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Höhne C, Fritz G, Keh D. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth 2008;101:781–7
105. Moraca RJ, Sheldon DG, Thirlby RC. The role of epidural anesthesia and analgesia in surgical practice. Ann Surg 2003;238:663–73
106. Fotiadis RJ, Badvie S, Weston MD, Allen-Mersh TG. Epidural analgesia in gastrointestinal surgery. Br J Surg 2004;91:828–41
107. Mythen MG, Webb AR. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 1994;20:99–104
108. Ackland G, Grocott MP, Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care 2000;4:269–81
109. Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, Newman MF, Mythen MG. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg 1999;89:514–9
110. Bennett-Guerrero E, Panah MH, Bodian CA, Methikalam BJ, Alfarone JR, DePerio M, Mythen MG. Automated detection of gastric luminal partial pressure of carbon dioxide during cardiovascular surgery using the Tonocap. Anesthesiology 2000;92:38–45
111. Lebuffe G, Vallet B, Takala J, Hartstein G, Lamy M, Mythen M, Bakker J, Bennett D, Boyd O, Webb A. A European, multicenter, observational study to assess the value of gastric-to-end tidal PCO2 difference in predicting postoperative complications. Anesth Analg 2004;99:166–72
112. Walsh SR, Tang TY, Farooq N, Coveney EC, Gaunt ME. Perioperative fluid restriction reduces complications after major gastrointestinal surgery. Surgery 2008;143:466–8
113. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet 2002;359:1812–8
114. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003; 238:641–8
115. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005; 103:25–32
116. MacKay G, Fearon K, McConnachie A, Serpell MG, Molloy RG, O'Dwyer PJ. Randomized clinical trial of the effect of postoperative intravenous fluid restriction on recovery after elective colorectal surgery. Br J Surg 2006;93:1469–74
117. Concha MR, Mertz VF, Cortinez LI, Gonzalez KA, Butte JM, Lopez F, Pinedo G, Zuniga A. The volume of lactated Ringer's solution required to maintain preload and cardiac index during open and laparoscopic surgery. Anesth Analg 2009;108:616–22
118. Vermeulen H, Hofland J, Legemate DA, Ubbink DT. Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial. Trials 2009;10:50
119. González-Fajardo JA, Mengibar L, Brizuela JA, Castrodeza J, Vaquero-Puerta C. Effect of postoperative restrictive fluid therapy in the recovery of patients with abdominal vascular surgery. Eur J Vasc Endovasc Surg 2009;37:538–43
120. Buettner M, Schummer W, Huettemann E, Schenke S, van Hout N, Sakka SG. Influence of systolic-pressure-variation-guided intraoperative fluid management on organ function and oxygen transport. Br J Anaesth 2008;101:194–9
121. McArdle GT, McAuley DF, McKinley A, Blair P, Hoper M, Harkin DW. Preliminary results of a prospective randomized trial of restrictive versus standard fluid regime in elective open abdominal aortic aneurysm repair. Ann Surg 2009;250:28–34
122. Harten J, Crozier JE, McCreath B, Hay A, McMillan DC, McArdle CS, Kinsella J. Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: a randomised controlled pilot study (ISRCTN 11799696). Int J Surg 2008;6:197–204
123. Bundgaard-Nielsen M, Secher NH, Kehlet H. ‘Liberal’ vs. ‘restrictive’ perioperative fluid therapy: a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53:843–51